4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-279721
Director acquired 29,600 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
DUNCAN BARBARA GAYLE · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-18 | Exercise or conversion : show line 1 in the form | +29,600 | 92,350 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-18 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −29,600 | 0 | D |
| 2026-06-18 | Grant or award : show line 3 in the form Restricted Stock Units | +26,700 | 26,700 | D |
| 2026-06-18 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +37,700 | 37,700 | D |
Loading xslF345X06/ownership.xml…